Home / Sweden / Hansa Biopharma AB

Hansa Biopharma AB

Short position disclosed on August 11, 2026.

2.08% of the capital sold short

3 disclosing funds

428 disclosures on record

SE0002148817 ISIN code

Funds holding Hansa Biopharma AB Titelia

Evolution of the disclosed total

0%2%4%6%

Oct 2025Jan 2026Apr 2026Jul 2026

Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.

The whole history, peaking at 4.82% on March 10, 2025. The shaded band is the year shown above.

January 15, 2019 today

Open positions

The funds disclosing a short position that is still open.
Fund	% of capital	Over the year	Since
ActusRayPartners Limited	0.89%	+0.29 pt	August 7, 2026
GSA Capital Partners LLP	0.60%	+0.06 pt	August 6, 2026
Connor Clark & Lunn Investment Management Ltd.	0.59%	-0.02 pt	August 11, 2026

History of disclosures

428 disclosures on record for this share.
Date	Fund	% of capital	End of publication
October 8, 2021	Worldquant LLC	0.76%	still open
October 8, 2021	Capital Fund Management SA	0.51%	still open
October 7, 2021	Marshall Wace LLP	0.99%	still open
October 5, 2021	Marshall Wace LLP	1.06%	still open
September 30, 2021	Worldquant LLC	0.61%	still open
September 24, 2021	Worldquant LLC	0.50%	still open
September 15, 2021	Marshall Wace LLP	1.18%	still open
September 2, 2021	Arrowstreet Capital Limited Partnership	0.88%	still open
September 1, 2021	Marshall Wace LLP	1.21%	still open
August 27, 2021	Marshall Wace LLP	1.10%	still open
August 27, 2021	Citadel Advisors LLC	0.00%	still open
August 23, 2021	Citadel Advisors LLC	0.57%	still open
August 19, 2021	Arrowstreet Capital Limited Partnership	0.90%	still open
August 18, 2021	Marshall Wace LLP	1.00%	still open
August 18, 2021	Worldquant LLC	0.00%	still open
August 13, 2021	Arrowstreet Capital Limited Partnership	0.81%	still open
August 11, 2021	Worldquant LLC	0.56%	still open
August 10, 2021	Citadel Advisors LLC	0.69%	still open
August 10, 2021	Worldquant LLC	0.60%	still open
August 9, 2021	Citadel Advisors LLC	0.74%	still open
August 5, 2021	Marshall Wace LLP	0.90%	still open
August 5, 2021	Citadel Advisors LLC	0.86%	still open
August 5, 2021	Arrowstreet Capital Limited Partnership	0.70%	still open
August 2, 2021	Citadel Advisors LLC	0.94%	still open
August 2, 2021	Marshall Wace LLP	0.83%	still open
July 29, 2021	Citadel Advisors LLC	0.85%	still open
July 28, 2021	Citadel Advisors LLC	0.90%	still open
July 28, 2021	Marshall Wace LLP	0.72%	still open
July 26, 2021	Worldquant LLC	0.51%	still open
July 22, 2021	Citadel Advisors LLC	0.80%	still open
July 22, 2021	PDT Partners LLC	0.00%	still open
July 21, 2021	Arrowstreet Capital Limited Partnership	0.68%	still open
July 20, 2021	Citadel Advisors LLC	0.79%	still open
July 20, 2021	Arrowstreet Capital Limited Partnership	0.71%	still open
July 20, 2021	Marshall Wace LLP	0.66%	still open
July 19, 2021	Citadel Advisors LLC	0.82%	still open
July 19, 2021	Marshall Wace LLP	0.70%	still open
July 19, 2021	PDT Partners LLC	0.53%	still open
July 16, 2021	Citadel Advisors LLC	0.98%	still open
July 16, 2021	Marshall Wace LLP	0.68%	still open
July 16, 2021	PDT Partners LLC	0.65%	still open
July 15, 2021	Citadel Advisors LLC	1.03%	still open
July 15, 2021	PDT Partners LLC	0.75%	still open
July 15, 2021	Marshall Wace LLP	0.54%	still open
July 12, 2021	Arrowstreet Capital Limited Partnership	0.69%	still open
July 9, 2021	Citadel Advisors LLC	0.81%	still open
July 7, 2021	Arrowstreet Capital Limited Partnership	0.70%	still open
July 2, 2021	Citadel Advisors LLC	0.70%	still open
June 28, 2021	Citadel Advisors LLC	0.62%	still open
June 24, 2021	PDT Partners LLC	0.00%	still open

Other companies sold short in Sweden

Samhällsbyggnadsbolaget i Norden AB 12.36% of the capital sold short
Elekta AB (publ) 10.19% of the capital sold short
JM AB 7.01% of the capital sold short
Hemnet Group AB (publ) 6.08% of the capital sold short
Bonesupport Holding AB 5.58% of the capital sold short
Truecaller AB 5.43% of the capital sold short
Embracer Group AB 5.25% of the capital sold short
Xvivo Perfusion Aktiebolag 4.91% of the capital sold short
Tobii AB 4.34% of the capital sold short
Dynavox Group AB 4.30% of the capital sold short
RaySearch Laboratories AB (publ) 4.15% of the capital sold short
Svenska Cellulosa Aktiebolaget SCA 3.77% of the capital sold short

Download as CSV

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Hansa Biopharma AB, source Finansinspektionen, data as at August 11, 2026, https://www.quivad.com/action/hansa-biopharma-ab?page=5